Brazil’s homegrown Butanvac trials to begin in June; 6 countries intend to import vaccine – state governor

Last week, Brazil's health regulator authorized the Butanvac clinical trials to begin. At this stage, the immunizer - which has undergone laboratory tests - will be administered to humans.

RIO DE JANEIRO, BRAZIL - São Paulo governor João Doria (PSDB) on Monday, June 14, said that clinical trials of the Butanvac vaccine, an immunizer against Covid-19 developed by the Butantan Institute, should begin by the end of June and that there are now 6 Latin American countries interested in its importation, should it be approved by the Brazilian Health Regulatory Agency (ANVISA) after trials are completed.

Last week, Brazil's health regulator authorized the Butanvac clinical trials to begin. At this stage, the immunizer - which has undergone laboratory tests - will be administered to humans.

According to Doria . . .

To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed?